Hemorrhagic complications of anticoagulant therapy.
D000284:Administration, Oral; D000818:Animals; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001241:Aspirin / Q000494:pharmacology; D001281:Atrial Fibrillation / Q000188:drug therapy; D002561:Cerebrovascular Disorders / Q000150:complications; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000150:complications; D004305:Dose-Response Relationship, Drug; D006350:Heart Valve Prosthesis; D006470:Hemorrhage / Q000139:chemically induced*; D006493:Heparin / Q000627:therapeutic use*; D006615:Hip / Q000601:surgery; D006801:Humans; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D010314:Partial Thromboplastin Time; D011446:Prospective Studies; D011479:Protamines / Q000627:therapeutic use; D011817:Rabbits; D012189:Retrospective Studies; D012306:Risk; D013923:Thromboembolism / Q000150:complications / Q000188:drug therapy / Q000517:prevention & control
D000925:Anticoagulants; D011479:Protamines; D006493:Heparin; D001241:Aspirin